Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy

Clinical trial NCT06582472 · RECRUITING

Trial details

NCT number: NCT06582472
Sponsor: IRCCS Ospedale San Raffaele
Status: RECRUITING
Study type: OBSERVATIONAL

Diabetic Retinopathy Diabetic Retinopathy Associated with Type 2 Diabetes Mellitus

Start date: 2023-09-29
Primary completion: 2025-05-19
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.